|
SafeMedicationUse Newsletter
|
|
Health Canada Endorsed Important Safety Information on Pradax (dabigatran) and Plavix (clopidogrel)
2011-11-08
Boehringer Ingelheim (Canada) Ltd. and Sanofi-aventis Canada Inc., in consultation with Health Canada, are alerting consumers to the risk of
medication errors associated with name confusion between the anticoagulant Pradax and the antiplatelet drug Plavix.
More information is available on the Health Canada website.
Read the previous SafeMedicationUse.ca alert Beware of Potential Confusion Between Pradax and Plavix.
|
